Why Pacira (PCRX) is Poised to Beat Earnings Estimates Again

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Pacira (PCRX) , which belongs to the Zacks Medical - Biomedical and Genetics industry, could be a great candidate to consider.When looking at the last two reports, this specialty drugmaker has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 7.77%, on average, in the last two quarters.For the last reported ...